Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-25
DOI
10.1038/s41467-020-19781-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation
- (2020) Davide Chicco et al. BMC GENOMICS
- Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
- (2020) Ombretta Melaiu et al. Frontiers in Immunology
- Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
- (2019) Wan-Chen Cheng et al. NATURE IMMUNOLOGY
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Exploiting NK Cell Surveillance Pathways for Cancer Therapy
- (2019) Alexander Barrow et al. Cancers
- A novel human IL2RB mutation results in T and NK cell–driven immune dysregulation
- (2019) Isabel Z. Fernandez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development
- (2019) Federica Riva et al. Cancer Immunology Research
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
- (2018) Paula Michea et al. NATURE IMMUNOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Immunological differences between primary and metastatic breast cancer
- (2018) B Szekely et al. ANNALS OF ONCOLOGY
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
- (2018) Wouter Scheper et al. NATURE MEDICINE
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Interleukin-12 from CD103 + Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of Metastasis
- (2017) Deepak Mittal et al. Cancer Immunology Research
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes
- (2016) Geoffrey J. Markowitz et al. CANCER RESEARCH
- Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells
- (2016) Andrew Jones et al. IMMUNITY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization
- (2016) Guangchuang Yu et al. Molecular BioSystems
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- BioGPS: building your own mash-up of gene annotations and expression profiles
- (2015) Chunlei Wu et al. NUCLEIC ACIDS RESEARCH
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
- (2015) Wenqian Zhang et al. GENOME BIOLOGY
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
- (2015) Marco Mina et al. OncoImmunology
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
- (2014) Brian Ruffell et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Shaping of an effective immune microenvironment to and by cancer cells
- (2014) Etienne Becht et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Trafficking of T Cells into Tumors
- (2014) C. Y. Slaney et al. CANCER RESEARCH
- Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system
- (2014) Thomas P. Stricker et al. Molecular Oncology
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
- (2014) L. Maldonado et al. Science Translational Medicine
- Tertiary lymphoid structures in cancer and beyond
- (2014) Marie-Caroline Dieu-Nosjean et al. TRENDS IN IMMUNOLOGY
- Can We Predict Mutant Neoepitopes in Human Cancers for Patient-Specific Vaccine Therapy?
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
- (2013) J. Goc et al. CANCER RESEARCH
- Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study
- (2013) J.A. Kohler et al. EUROPEAN JOURNAL OF CANCER
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
- (2013) H Kocak et al. Cell Death & Disease
- CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma
- (2012) Greg Parsonage et al. AMERICAN JOURNAL OF PATHOLOGY
- NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data
- (2012) Daryl Waggott et al. BIOINFORMATICS
- ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
- (2012) Trude H Ågesen et al. GUT
- Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
- (2012) Nadia R Cohen et al. NATURE IMMUNOLOGY
- A gene expression signature identifies two prognostic subgroups of basal breast cancer
- (2010) Renaud Sabatier et al. BREAST CANCER RESEARCH AND TREATMENT
- Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma
- (2010) Maria Antonietta De Ioris et al. EUROPEAN JOURNAL OF CANCER
- Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1
- (2010) Hervé Rubie et al. JOURNAL OF CLINICAL ONCOLOGY
- Peripheral CD103+dendritic cells form a unified subset developmentally related to CD8α+conventional dendritic cells
- (2010) Brian T. Edelson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
- (2008) B De Bernardi et al. BRITISH JOURNAL OF CANCER
- Expression and function of toll like receptors in chronic lymphocytic leukaemia cells
- (2008) Marta Muzio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
- (2008) Marie-Caroline Dieu-Nosjean et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now